2024
Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients.
Ayyagari R, Rahman S, Grizzard K, Mustafa A, Staib L, Makkia R, Bhatia S, Bilhim T, Carnevale F, Davis C, Fischman A, Isaacson A, McClure T, McWilliams J, Nutting C, Richardson A, Salem R, Sapoval M, Yu H. Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients. Radiology 2024, 310: e231877. PMID: 38441098, DOI: 10.1148/radiol.231877.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationCumulative air kermaRadiation-related adverse eventsBody mass indexAdverse eventsEffective doseFluoroscopy timeArtery embolizationRadiation doseKerma area product valuesMedian cumulative air kermaMedian effective radiation doseFluoroscopy unitPatient body mass indexRadiation exposureTwo-sample <i>t</i> test wasRadiation dose dataBenign prostatic hyperplasiaFluoroscopy-guided proceduresPatient radiation exposureEffective radiation doseRadiation field areaRadiation effective doseWilcoxon rank sum testInvasive angiographic procedures
2021
Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention
Powell T, Staib L, Liu B, Bhatia S, Chai T, Ayyagari R. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention. Urology 2021, 156: 216-224. PMID: 33961894, DOI: 10.1016/j.urology.2021.02.046.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsProstate artery embolizationBenign prostatic hyperplasiaUrinary tract symptomsLUTS patientsIPSS-VUrinary retentionRetention patientsArtery embolizationTract symptomsTotal International Prostate Symptom ScoreDomain scoresInternational Prostate Symptom ScoreComponent scoresProstate Symptom ScoreSingle centerSymptom scoresLife scoresProstatic hyperplasiaIPSSPatientsPre-PAEQoLMonthsScore outcomes
2019
Prostatic Artery Embolization Using 100–300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up
Ayyagari R, Powell T, Staib L, Chapiro J, Raja A, Bhatia S, Chai T, Schoenberger S, Devito R. Prostatic Artery Embolization Using 100–300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up. Journal Of Vascular And Interventional Radiology 2019, 31: 99-107. PMID: 31771896, DOI: 10.1016/j.jvir.2019.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAcrylic ResinsAge FactorsAgedAged, 80 and overComorbidityCone-Beam Computed TomographyConnecticutEmbolization, TherapeuticGelatinHumansLower Urinary Tract SymptomsMaleMiddle AgedOrgan SizeParticle SizeProstateProstatic HyperplasiaQuality of LifeRecovery of FunctionRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeConceptsInternational Prostate Symptom ScoreLower urinary tract symptomsPost-void residualCharlson Comorbidity IndexProstatic artery embolizationProstate gland volumeMedian lobe enlargementBenign prostatic hyperplasiaTrisacryl gelatin microspheresArtery embolizationProstatic hyperplasiaGland volumeAdverse event recordingMedical therapy failureClavien-Dindo classificationProstate Symptom ScoreMedium-term followUrinary tract symptomsLower urinary tractMedium-term outcomesPost-procedure valuesQuality of lifeComorbidity indexTract symptomsConsecutive patientsProstatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria
Ayyagari R, Powell T, Staib L, Chapiro J, Perez-Lozada JC, Bhatia S, Chai T, Schoenberger S, Devito R. Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria. Urology 2019, 136: 212-217. PMID: 31734349, DOI: 10.1016/j.urology.2019.11.003.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationBenign prostatic hyperplasia patientsProstatic hyperplasia patientsInternational Prostate Symptom ScoreProstatic hematuriaHyperplasia patientsUrinary retentionArtery embolizationPostvoid residualHematuria patientsSingle-center outcomesUrinary retention patientsClavien-Dindo classificationProstate Symptom ScoreQuality of lifeTransfusion rateGross hematuriaSH patientsUrinary infectionBladder irrigationGH patientsSymptom scoresUR patientsBladder tumorsDurable treatmentCase-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia
Ayyagari R, Powell T, Staib L, Chapiro J, Schoenberger S, Devito R, Pollak J. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia. Journal Of Vascular And Interventional Radiology 2019, 30: 1459-1470. PMID: 31375451, DOI: 10.1016/j.jvir.2019.05.033.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationBenign prostatic hyperplasiaEH groupArtery embolizationSymptomatic improvementAdverse eventsProstatic hyperplasiaInternational Prostate Symptom Score improvementTrial successSymptomatic benign prostatic hyperplasiaBO groupContrast material useProstatic artery anatomySymptom score improvementAdverse event ratesProcedural metricsResidual improvementCase-control comparisonClinical improvementRetrospective reviewArtery anatomyMicrocatheter selectionContrast materialScore improvementEvent ratesScoring of Coronary Artery Disease Characteristics on Coronary CT Angiograms by Using Machine Learning
Johnson KM, Johnson HE, Zhao Y, Dowe DA, Staib LH. Scoring of Coronary Artery Disease Characteristics on Coronary CT Angiograms by Using Machine Learning. Radiology 2019, 292: 182061. PMID: 31237495, DOI: 10.1148/radiol.2019182061.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary VesselsFemaleHumansImage Interpretation, Computer-AssistedMachine LearningMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRisk FactorsSeverity of Illness IndexYoung AdultConceptsCoronary CT angiographyCoronary Artery Disease ReportingNonfatal myocardial infarctionHeart disease deathCT angiographyCause mortalityDisease deathsMyocardial infarctionCoronary heart disease deathDisease reportingCoronary artery diseaseNational Death IndexData System scoreCardiovascular eventsCoronary deathAdverse eventsArtery diseaseCoronary diseaseDeath IndexCoronary segmentsPrognostic informationVessel scorePatientsSystem scoreSubsequent death
2018
Benefit of a Visual Aid in the Management of Moderate-Severity Contrast Media Reactions.
Gardner JB, Rashid S, Staib L, Asch D, Cavallo J, Arango J, Kirsch J, Pahade J. Benefit of a Visual Aid in the Management of Moderate-Severity Contrast Media Reactions. American Journal Of Roentgenology 2018, 211: 717-723. PMID: 30106614, DOI: 10.2214/ajr.18.19689.Peer-Reviewed Original Research
2017
Disparities in Care Among Patients With Cardiac Implantable Electronic Devices Undergoing MRI
Cavallo JJ, Zhang Y, Staib LH, Lampert R, Weinreb JC. Disparities in Care Among Patients With Cardiac Implantable Electronic Devices Undergoing MRI. Journal Of The American College Of Radiology 2017, 14: 1566-1571. PMID: 28899705, DOI: 10.1016/j.jacr.2017.07.014.Peer-Reviewed Original Research
2016
Knowledge of Density and Screening Ultrasound
Moothathu NS, Philpotts LE, Busch SH, Gross CP, Staib LH, Hooley RJ. Knowledge of Density and Screening Ultrasound. The Breast Journal 2016, 23: 323-332. PMID: 27943500, DOI: 10.1111/tbj.12734.Peer-Reviewed Original ResearchConceptsBreast density awarenessBreast densityDense breast tissueScreening ultrasoundBreast cancerCaucasian raceBreast tissueBreast ultrasoundSupplemental breast ultrasoundBreast cancer riskBreast density notification lawsNon-Caucasian patientsPercent of participantsPhysician recommendationProvider recommendationAcademic breastSelf-administered surveyUltrasoundWomenPatientsCancerMammography reportsTissueAnxietyHigher incomeIs there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
Pahade JK, Juice D, Staib L, Israel G, Cornfeld D, Mitchell K, Weinreb J. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies? Abdominal Radiology 2016, 41: 1270-1284. PMID: 26800701, DOI: 10.1007/s00261-016-0635-9.Peer-Reviewed Original Research
2015
High-Fidelity Contrast Reaction Simulation Training: Performance Comparison of Faculty, Fellows, and Residents
Pfeifer K, Staib L, Arango J, Kirsch J, Arici M, Kappus L, Pahade J. High-Fidelity Contrast Reaction Simulation Training: Performance Comparison of Faculty, Fellows, and Residents. Journal Of The American College Of Radiology 2015, 13: 81-87. PMID: 26549266, DOI: 10.1016/j.jacr.2015.08.016.Peer-Reviewed Original ResearchThe clinical impact of gynecologic MRI.
Ratner ES, Staib LH, Cross SN, Raji R, Schwartz PE, McCarthy SM. The clinical impact of gynecologic MRI. American Journal Of Roentgenology 2015, 204: 674-80. PMID: 25714302, DOI: 10.2214/ajr.14.12567.Peer-Reviewed Original ResearchConceptsPelvic MRIFirst modalityClinical managementClinical impactGynecologic massesIndeterminate pelvic massesGroup of patientsResults of MRIRadiologic recordsRadiologic findingsPelvic massClinical recordsUnnecessary surgeryMedical recordsCT examinationsFurther endpointsExact diagnosisPatientsSurgeryIndeterminate massesPatient treatmentMRIDiagnosisModalitiesResultant anxiety
2014
Using SUV as a Guide to 18F-FDG Dose Reduction
Cheng DW, Ersahin D, Staib LH, Della Latta D, Giorgetti A, d’Errico F. Using SUV as a Guide to 18F-FDG Dose Reduction. Journal Of Nuclear Medicine 2014, 55: 1998-2002. PMID: 25453048, DOI: 10.2967/jnumed.114.140129.Peer-Reviewed Original Research
2012
The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid Cancer
Chen MK, Yasrebi M, Samii J, Staib LH, Doddamane I, Cheng DW. The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid Cancer. Thyroid 2012, 22: 304-309. PMID: 22300251, DOI: 10.1089/thy.2011.0203.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma, PapillaryAdenoma, OxyphilicAdolescentAdultAgedAged, 80 and overCarcinomaCarcinoma, PapillaryFemaleHumansIodine RadioisotopesMaleMiddle AgedNeoplasm MetastasisRadionuclide ImagingRadiopharmaceuticalsRetrospective StudiesThyroid Cancer, PapillaryThyroid NeoplasmsThyroidectomyConceptsPretherapy scansThyroid remnantsLymph nodesDistant metastasisYale-New Haven HospitalLarge thyroid remnantsCervical lymph nodesTime of thyroidectomyAdditional clinical informationNew Haven HospitalNeck uptakeRadioiodine therapyWhole-body imagesEuthyroid statePathology reportsThyroid cancerTreatment protocolLocal lymphClinical informationThyroidectomy specimensPretherapyConfidence intervalsScansThyroidectomyMetastasisGender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study
Tandon S, Wackers F, Inzucchi SE, Bansal S, Staib LH, Chyun DA, Davey JA, Young LH. Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study. Diabetes And Vascular Disease Research 2012, 9: 124-130. PMID: 22228772, DOI: 10.1177/1479164111431470.Peer-Reviewed Original ResearchMeSH KeywordsAgedAsymptomatic DiseasesCanadaCardiovascular DiseasesDiabetes ComplicationsDiabetes Mellitus, Type 2FemaleHumansIncidenceKaplan-Meier EstimateMaleMass ScreeningMiddle AgedMyocardial Perfusion ImagingPredictive Value of TestsPrognosisProspective StudiesRisk AssessmentRisk FactorsSex FactorsTime FactorsUnited StatesConceptsType 2 diabetesMyocardial perfusion imagingCardiovascular outcomesStress myocardial perfusion imagingAsymptomatic Diabetics (DIAD) studyBetter cardiac outcomesHigh-risk womenCoronary artery diseaseHigh-risk menDetection of ischemiaMPI abnormalitiesAsymptomatic patientsAsymptomatic menCardiac eventsCardiac outcomesArtery diseaseAsymptomatic womenAbnormal screeningDiabetic studyPerfusion imagingDIAD studyWomenMenDiabetesOutcomes
2010
Five-Year Outcomes in High-Risk Participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study A post hoc analysis
Bansal S, Wackers FJ, Inzucchi SE, Chyun DA, Davey JA, Staib LH, Young LH, . Five-Year Outcomes in High-Risk Participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study A post hoc analysis. Diabetes Care 2010, 34: 204-209. PMID: 20929989, PMCID: PMC3005488, DOI: 10.2337/dc10-1194.Peer-Reviewed Original ResearchConceptsCardiac event rateBaseline cardiovascular riskAnnual cardiac event rateHigh cardiovascular riskCardiovascular riskHigh-risk participantsDetection of ischemiaEvent ratesInducible ischemiaRisk engineUK Prospective Diabetes Study risk engineHigh baseline cardiovascular riskAsymptomatic Diabetics (DIAD) studyFive-year outcomesUKPDS risk engineLow-risk groupRisk stratification approachStudy of DiabetesLow-risk participantsAsymptomatic diabeticsCardiac eventsFramingham scoreMetabolic syndromeRisk groupsDiabetic study
2001
Automated measurement of latent morphological features in the human corpus callosum
Peterson B, Feineigle P, Staib L, Gore J. Automated measurement of latent morphological features in the human corpus callosum. Human Brain Mapping 2001, 12: 232-245. PMID: 11241874, PMCID: PMC6871880, DOI: 10.1002/1097-0193(200104)12:4<232::aid-hbm1018>3.0.co;2-j.Peer-Reviewed Original ResearchConceptsCorpus callosumSubject characteristicsYears of ageHuman corpus callosumPatient groupCallosum sizeHealthy subjectsMRI scansVentricular volumeCallosumMidsagittal planeFactor scoresNeural correlatesConstruct validityFactor-based analysisConventional measuresFuture studiesMorphological featuresAgePredictive validitySubjectsScoresNormal developmentVarimax rotationFactors
2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder
Bremner J, Innis R, White T, Fujita M, Silbersweig D, Goddard A, Staib L, Stern E, Cappiello A, Woods S, Baldwin R, Charney D. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biological Psychiatry 2000, 47: 96-106. PMID: 10664825, DOI: 10.1016/s0006-3223(99)00188-2.Peer-Reviewed Original ResearchConceptsBenzodiazepine receptor bindingBenzodiazepine receptor functionPanic disorder patientsBenzodiazepine receptorsPanic disorderReceptor bindingDisorder patientsPanic attacksReceptor functionPrefrontal cortexSingle photon emissionStatistical parametric mappingGABAergic transmissionHealthy controlsFrontal cortexLeft hippocampusAnimal modelsComparison subjectsPatientsChronic stressPanic anxietyTomography imagingParametric mappingCortexSpecific decrease